Protara Therapeutics, Inc.
USD4.09
+0.02 (+0.49%)
CEO
Jesse Shefferman
IPO Date
2014-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.10
Prev. Close
$4.07
Day Low
$4.07
Day High
$4.13
52W Low
$2.97
52W High
$7.82
Market Cap
$0.16B
Volume
0.29M
| 215,687 |
| $4.09 |
| 1 Jul 2026 | Shefferman Jesse | director, officer: CEO and President | G-Gift | Disposed | 14,000 | $0.00 |
| 1 Jul 2026 | Shefferman Jesse | director, officer: CEO and President | G-Gift | Disposed | 7,000 | $0.00 |
| 1 Jul 2026 | Shefferman Jesse | director, officer: CEO and President | G-Gift | Disposed | 4,000 | $0.00 |
| 1 Jul 2026 | Shefferman Jesse | director, officer: CEO and President | G-Gift | Disposed | 5,000 | $0.00 |
| 1 Jul 2026 | Shefferman Jesse | director, officer: CEO and President | M-Exempt | Disposed | 215,687 | $1.91 |
| 16 Jun 2026 | Levy Richard S | director | A-Award | Acquired | 31,000 | $3.94 |
| 16 Jun 2026 | Solomon Michael Edward | director | A-Award | Acquired | 31,000 | $3.94 |
| 16 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 31,000 | $3.94 |